Literature DB >> 8301208

Effects of endotoxin injury on endothelial cell adenosine metabolism.

S Rounds1, L Hsieh, K C Agarwal.   

Abstract

Adenosine is a potent autocoid that acts as a vasodilator and modulator of inflammatory responses. Endothelial cells possess several mechanisms for altering circulating levels of adenosine and are capable of release of adenosine metabolites. We used cultured bovine aortic and main pulmonary arterial endothelial cells to determine whether endotoxin can alter adenosine uptake or release of adenosine metabolites. We found that 24 hours, but not 6 hours, of incubation with endotoxin caused endothelial cell injury, as assessed by cell detachment and chromium 51 release. Despite this injury the extent of [3H]adenosine uptake was unchanged. Using thin-layer chromatography to identify adenosine and its metabolites, we found that [3H]adenosine was primarily metabolized into intracellular hypoxanthine and adenine nucleotides. After 1, 6, and 24 hours of incubation with endotoxin there was an increase in extracellular adenosine metabolites, which was accompanied by decreases in the level of intracellular adenosine 5'-triphosphate. The appearance of adenosine metabolites in culture supernatants was a more sensitive measure of endothelial cell injury than 51Cr release or adherent cell number. The extracellular purine metabolite observed in response to endotoxin injury was mainly hypoxanthine. Our findings suggest that hypoxanthine release is an early event in endotoxin-induced endothelial cell injury. Because hypoxanthine may act as a substrate for xanthine oxidase, resulting in toxic oxidant production, its release has the potential of exacerbating vascular injury caused by endotoxin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8301208

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  5 in total

Review 1.  Adenosine receptors and asthma.

Authors:  Constance N Wilson; Ahmed Nadeem; Domenico Spina; Rachel Brown; Clive P Page; S Jamal Mustafa
Journal:  Handb Exp Pharmacol       Date:  2009

2.  Comparison of various lazaroid compounds for protection against ischemic liver injury.

Authors:  N Ishizaki; Y Zhu; S Zhang; A Nemoto; Y Kobayashi; V M Subbotin; R G Lee; T E Starzl; S Todo
Journal:  Transplant Proc       Date:  1997 Feb-Mar       Impact factor: 1.066

Review 3.  Shaping of monocyte and macrophage function by adenosine receptors.

Authors:  György Haskó; Pál Pacher; Edwin A Deitch; E Sylvester Vizi
Journal:  Pharmacol Ther       Date:  2006-09-14       Impact factor: 12.310

4.  A Pilot Study to Assess Adenosine 5'-triphosphate Metabolism in Red Blood Cells as a Drug Target for Potential Cardiovascular Protection.

Authors:  Pollen K F Yeung; Jodi Tinkel; Dena Seeto
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2016

Review 5.  Adenosine 5'-Triphosphate Metabolism in Red Blood Cells as a Potential Biomarker for Post-Exercise Hypotension and a Drug Target for Cardiovascular Protection.

Authors:  Pollen K Yeung; Shyam Sundar Kolathuru; Sheyda Mohammadizadeh; Fatemeh Akhoundi; Brett Linderfield
Journal:  Metabolites       Date:  2018-05-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.